Using a humanised murine model of FA we demonstrated that treatment with the stem cell mobilising cytokines granulocyte-colony stimulating factor (G-CSF) and stem cell factor had pronounced effects on frataxin levels within the nervous system and improved clinical, biochemical and pathological parameters associated with the disease10,11. Here, FXN is linked to Friedreich ataxia.